Literature DB >> 1974828

Poxviruses: an emerging portrait of biological strategy.

P Traktman1.   

Abstract

The meeting offered ample evidence that the field of poxvirology has truly come of age. Many investigators were attracted to the field by its experimental feasibility; indeed, the virions are "in vitro transcription systems" and the genome is a "cDNA library." The viral life cycle is synchronous and rapid and can be studied genetically and biochemically in a wide range of cell types. What has become clear is that the virus also offers a unique opportunity to dissect a range of biological problems. The enzymes involved in nucleic acid metabolism are numerous and easily accessible to study; vaccinia is fast evolving into a model system of choice for structure-function studies. The cascade of gene expression offers a chance to investigate in detail the mechanism of trans-acting factors that determine transcriptional specificity, as well as a system to probe the role of genome "chromatin" in dictating the accessibility of transcriptional units. But perhaps the most lasting impression of vaccinia is as a virus that encodes a unique repertoire of proteins governing its survival within the host. Among these are proteins that may activate the next round of cells to be infected, reduce the activation of cells responsible for the inflammatory response, and sabotage the biochemical cascades of host defenses. Never before has a virus held up a mirror so intriguing and so informative.

Mesh:

Substances:

Year:  1990        PMID: 1974828     DOI: 10.1016/0092-8674(90)90106-o

Source DB:  PubMed          Journal:  Cell        ISSN: 0092-8674            Impact factor:   41.582


  20 in total

1.  Transient expression of the vaccinia virus DNA polymerase is an intrinsic feature of the early phase of infection and is unlinked to DNA replication and late gene expression.

Authors:  W F McDonald; V Crozel-Goudot; P Traktman
Journal:  J Virol       Date:  1992-01       Impact factor: 5.103

2.  Vaccinia virus DNA replication: two hundred base pairs of telomeric sequence confer optimal replication efficiency on minichromosome templates.

Authors:  S Du; P Traktman
Journal:  Proc Natl Acad Sci U S A       Date:  1996-09-03       Impact factor: 11.205

3.  Distinct domains of M-T2, the myxoma virus tumor necrosis factor (TNF) receptor homolog, mediate extracellular TNF binding and intracellular apoptosis inhibition.

Authors:  M Schreiber; L Sedger; G McFadden
Journal:  J Virol       Date:  1997-03       Impact factor: 5.103

4.  Mutations in active-site residues of the uracil-DNA glycosylase encoded by vaccinia virus are incompatible with virus viability.

Authors:  K S Ellison; W Peng; G McFadden
Journal:  J Virol       Date:  1996-11       Impact factor: 5.103

5.  A poxvirus protein with a RING finger motif binds zinc and localizes in virus factories.

Authors:  C Upton; L Schiff; S A Rice; T Dowdeswell; X Yang; G McFadden
Journal:  J Virol       Date:  1994-07       Impact factor: 5.103

6.  Identification of a poxvirus gene encoding a uracil DNA glycosylase.

Authors:  C Upton; D T Stuart; G McFadden
Journal:  Proc Natl Acad Sci U S A       Date:  1993-05-15       Impact factor: 11.205

7.  Disruption of M-T5, a novel myxoma virus gene member of poxvirus host range superfamily, results in dramatic attenuation of myxomatosis in infected European rabbits.

Authors:  K Mossman; S F Lee; M Barry; L Boshkov; G McFadden
Journal:  J Virol       Date:  1996-07       Impact factor: 5.103

8.  Chromosome mapping of Rmp-4, a gonad-dependent gene encoding host resistance to mousepox.

Authors:  D G Brownstein; L Gras
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

9.  Membrane-bound complement regulatory activity is decreased on vaccinia virus-infected cells.

Authors:  L Baranyi; N Okada; K Baranji; H Takizawa; H Okada
Journal:  Clin Exp Immunol       Date:  1994-10       Impact factor: 4.330

10.  Identification and characterization of an extracellular envelope glycoprotein affecting vaccinia virus egress.

Authors:  S A Duncan; G L Smith
Journal:  J Virol       Date:  1992-03       Impact factor: 5.103

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.